Literature DB >> 15586032

Lasers in the treatment of benign prostatic hyperplasia: an update.

Andrew H Tan1, Peter J Gilling.   

Abstract

PURPOSE OF REVIEW: Few of the original laser-based procedures from the early 1990s have withstood the test of time while some, such as holmium laser prostatectomy, have been significantly modified. New additions to the fold, such as the high-powered potassium-titanyl-phosphate (KTP) laser, use old techniques and disposables but a higher level of energy than previously. In the 12 months since September 2003, a number of important articles have appeared concerning laser prostatectomy, the subject of this review. RECENT
FINDINGS: Holmium laser enucleation of the prostate has been shown to result in greater relief of bladder outflow obstruction than transurethral resection of the prostate, which is a first for an endoscopic procedure. Durability beyond 4 years has also been confirmed. Concerns regarding the histology of the retrieved tissue and the learning curve have been clarified. Early results for 'photoselective' (KTP) vaporization of the prostate have been published confirming the lack of short-term morbidity. Its use on an outpatient basis has been tested in a small number of patients, and canine studies have confirmed less bleeding than with transurethral resection but inferior efficiency. Interstitial laser coagulation has been reviewed unfavourably and the results with contact laser vaporization have been variable.
SUMMARY: New studies of holmium laser enucleation have confirmed its efficacy and durability, though training and company support remain problematic and its acceptance has been slow. The KTP laser is beginning to accumulate some support in the literature though its 'honeymoon phase' is still in evidence. Randomized studies are needed. Interstitial laser coagulation and contact laser vaporization appear to be in decline.

Entities:  

Mesh:

Year:  2005        PMID: 15586032     DOI: 10.1097/00042307-200501000-00013

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  8 in total

Review 1.  New laser treatment approaches for benign prostatic hyperplasia.

Authors:  Nathaniel M Fried
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

2.  [Functional outcome after laser vaporisation of the prostate with the KTP laser].

Authors:  M F Hamann; C Wild; C Seif; S Hautmann; K P Jünemann; P M Braun
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

3.  [Benign prostatic syndrome (BPS). Ablative treatments].

Authors:  O Reich; M Seitz; C Gratzke; B Schlenker; A Bachmann; C Stief
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

4.  Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01

Review 5.  [Benign prostatic hyperplasia (BPH) : Surgical therapy options].

Authors:  O Reich; M Seitz; C Gratzke; B Schlenker; S Walther; C Stief
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

6.  Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades.

Authors:  Se Young Choi; Tae-Hyoung Kim; Soon Chul Myung; Young Tae Moon; Kyung Do Kim; Young Sun Kim; Hye-Ryoun Kim; In Ho Chang
Journal:  Korean J Urol       Date:  2012-01-25

7.  The one year outcome after KTP laser vaporization of the prostate according to the calculated vaporized volume.

Authors:  Ja Hyeon Ku; Jeong Yeon Cho; Sung Yong Cho; Soo Woong Kim; Jae-Seung Paick
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

8.  Can 80 W KTP Laser Vaporization Effectively Relieve the Obstruction in Benign Prostatic Hyperplasia?: A Nonrandomized Trial.

Authors:  Deok Hyun Han; Seol Ho Choo; Jin Woo Chung; Jeong Hee Hong; Sung Won Lee
Journal:  World J Mens Health       Date:  2012-12-27       Impact factor: 5.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.